Bariatric surgery is becoming increasingly common in the UK. Little has been done to evaluate its place in HIV-positive patients. Here, we discuss a successful case and the complexities surrounding highly active antiretroviral therapy.
WangCMcPhersonKMarshT. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet2011; 9793: 815–825.
2.
CofrancescaJFreedlandEMcComseyG. Treatment options for HIV-associated central fat accumulation. AIDS Patient Care STDs2009; 23: 5–18.
3.
Crum-CianfloneNTejidorTMedineS. Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS One [internet]2010; 5: e10106–e10106.
4.
GloyVBrielMBhattD. Bariatric surgery versus non surgical treatment for obesity: a systemic review and meta-analysis of random controlled trials. BMJ2013; 347: f5934–f5934.
5.
Razonable R, Estes L, McMahon M, et al, Gastric bypass surgery and serum concentrations of zidovudine, lamivudine and nelfinavir. The XIV International AIDS conference Barcelona, Spain 7–12 July 2002, Abstract no. B10386.
6.
FazylovRSotoEMerolaS. Laparoscopic gastric bypass surgery in human immunodeficiency virus-infection patients. Surg Obes Relat Dis2007; 3: 637–639.
7.
SelkeHNorrisSOsterholzerD. Bariatric surgery outcomes in HIV-infected subjects: a case series. AIDS Patient Care STDs2010; 24: 545–550.
8.
FlancbaumLDrakeVColarussoT. Initial experience with bariatric surgery in asymptomatic human immunodeficiency virus-infected patients. Surg Obes Relat Dis2005; 2: 73–76.
